ASEP Medical Holdings Inc. (ASEP.CN)
| Previous Close | 0.2750 |
| Open | 0.2700 |
| Bid | 0.2350 x N/A |
| Ask | 0.2700 x N/A |
| Day's Range | 0.2200 - 0.2800 |
| 52 Week Range | 0.0600 - 0.6700 |
| Volume | |
| Avg. Volume | 116,804 |
| Market Cap | 15.282M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0800 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CNW GroupASEP ANNOUNCES PRIVATE PLACEMENT OF UP TO $2 MILLION
Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) is pleased to announce a non-brokered private placement of up to 10,000,000 units of the Company (each, a "Unit") at a price of $0.20 per Unit, for aggregate gross proceeds of up to $2,000,000 (the "Offering").
CNW GroupAsep Medical Holdings Inc. is Granted Patent Approval for its AI-based Sepsis Diagnostic Technology in the US
Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that the Company's AI-based sepsis diagnostic technology, called SepsetER TM, has received successful patent approval in the United States. The Company received confirmation from its attorneys of its US Patent Application No. 16/279788, which has been subsequently validated in the US, representing 332 million people. This patent is in addition to the successful European and Aust
CNW GroupAsep Medical Holdings Inc. Signs Joint Venture Agreement with Leading Chinese Medical Diagnostics Company Sansure Biotech Inc.
Asep Medical Holdings Inc. ("Asep" or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is very pleased to announce that, through its subsidiary Sepset Biosciences Inc. ("Sepset"), it has signed a definitive joint venture agreement (the "JV Agreement") with leading Chinese medical diagnostic company, Sansure Biotech Inc. ("Sansure"), through its subsidiary, Hunan Xiang Jiang Sansure Biotech Fund, L.P. (the "Sansure Fund"). Sansure Fund is an investment fund formed by Sansure, Changsha Sanway
